Vaxcyte PCVX Insider Ownership

Updated Nov 5, 2026

In the last 12 months, insiders at Vaxcyte made open-market sales of $12.74 million (211.99K shares) and bought no shares on the open market.

• Vaxcyte's open-market sales in the past 12 months came from 5 insiders; no insider bought.
• Grant Pickering (Chief Executive Officer) led open-market sales of Vaxcyte stock over the past 12 months with $3.63 million (66.9K shares), most recently on July 27, 2026.
• Elvia Cowan (SVP, Finance & CAO) made the most recent open-market trade by an insider of Vaxcyte, a sale of 3K shares for $182,753 on November 2, 2026.
• Apart from open-market trades, PCVX insiders received 309.66K shares in stock awards, acquired 126.16K shares through option exercises and conversions, gave up 66.54K shares to cover taxes or exercise prices and gave away 162.85K shares as gifts in the past 12 months.
• Per Business Quant data, Vaxcyte insiders hold 1.28Mn shares in total based on their latest Form 4 filings, or 0.88% of the 144.79Mn shares outstanding; that total is down 0.26% from 1.28Mn shares at the end of Q2 2026 and up 4.97% from 1.21Mn shares at the end of Q3 2025.
• Of the 1.28Mn shares held by Vaxcyte insiders, 941.49K shares (73.82%) are held directly and 333.9K shares (26.18%) indirectly, through trusts, partnerships, family members and other entities.
• Holdings in Vaxcyte stock are reported by 15 insiders, the officers, directors and 10% owners who have filed a Form 4 in the past two years.
• PCVX's largest insider holders by reported holdings are Grant Pickering (Chief Executive Officer, 696.33K shares), Andrew Guggenhime (President and CFO, 157.17K shares) and Jim Wassil (EVP, Chief Scientific Officer, COO, 145.44K shares).
• The holding of Grant Pickering makes up 54.60% of all shares held by Vaxcyte insiders.
• In the last 12 months, 55 Form 4 filings with transactions in PCVX stock came from 16 insiders.
• This summary of Vaxcyte insider activity covers Form 4 filings through November 4, 2026.